行情

BNTC

BNTC

Benitec
NASDAQ

实时行情|Nasdaq Last Sale

5.28
+0.43
+8.87%
已收盘, 16:00 02/19 EST
开盘
4.727
昨收
4.850
最高
5.45
最低
4.727
成交量
12.23万
成交额
--
52周最高
22.70
52周最低
4.130
市值
6,785.58万
市盈率(TTM)
2.383
分时
5日
1月
3月
1年
5年

EPS

BNTC 新闻

  • 中通3月17日发布2019财年第四季度及全年财报
  • 新浪科技.1小时前
  • 英国零售销售创近两年来最大涨幅 英镑反弹
  • 新浪财经.1小时前
  • 马斯克斥资1000万美元 购入特斯拉1.3万股股票
  • 新浪科技.1小时前
  • 英国1月份零售销售环比增长0.9% 预估增长0.7%
  • 新浪财经.1小时前

更多

所属板块

生物技术和医学研究
+1.01%
制药与医学研究
+0.22%

热门股票

名称
价格
涨跌幅

BNTC 简况

Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. Its In-house product candidates include TT-034, BB-HB-331, BB-AMD-211 and ddRNAi therapeutic. It is focused on commercialization by licensing and partnering of patents and licenses in biotechnology, in functional genomics, with applications in biomedical research and human therapeutics. It has a pipeline of in-house and partnered therapeutic programs based on its patented gene-silencing technology, deoxyribonucleic acid (DNA)-directed ribonucleic acid interference (ddRNAi). The Company is engaged in developing treatments for chronic human conditions, such as hepatitis B, wet age-related macular degeneration (AMD), and oculopharyngeal muscular dystrophy (OPMD) based on this technology.
展开

Webull提供Benitec Biopharma Ltd的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。